Factor (F)viii/VIIa Enhances Global Haemostatic Function in the Co-Presence of Bypassing Agents and FVIII Among Patients With Haemophilia a With Inhibitor

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15209
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

Recombinant Factor VIIa for the Prevention and Treatment of Bleeding in Patients Without Haemophilia

2007English

Long-Term Treatment Course of a Patient With Mild Haemophilia a Who Developed a High Titre Factor VIII Inhibitor

Haemophilia
MedicineGeneticsHematology
2014English

Management of Coagulation Factor VIII (FVIII) Inhibitors

Thrombosis Research
Hematology
2019English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study

British Journal of Haematology
Hematology
2017English

Citrate Artificially Masks the Haemostatic Effect of Recombinant Factor VIIa in Dilutional Coagulopathy

Annals of Hematology
MedicineHematology
2008English

Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice

Biopharmaceutics and Drug Disposition
MedicinePharmacologyPharmaceutical Science
2016English

Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy